Clinical trial
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
NCT07028489 is registered in ClinicalTrials.gov with N-Power Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
- Lead sponsor
- N-Power Medicine
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 5, 2025
- Completion date
- April 30, 2029
- Enrollment
- 130 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
non small cell lung cancer